Loading
Every cancer trial's anonymised patient-level data would go into one trusted repository within eighteen months of completion, with a single access committee, so researchers can re-analyse, pool and learn from trials that today stay locked up.
Consolidate the existing sharing platforms (Vivli, Project Data Sphere, YODA, ClinicalStudyDataRequest) into a single oncology data trust with a legal duty to deposit individual participant data, protocols and analysis code within eighteen months of primary completion for all trials whose results support a regulatory decision or that receive public funding. One independent access committee, standard data formats (CDISC), a secure analysis environment and a public catalogue. Trials in oncology already have among the highest voluntary sharing rates but access remains slow and fragmented, and negative or discontinued trials are rarely deposited at all.
Shares An antitrust safe harbour for cross-company combination trials and data pooling, A federated learning consortium of cancer centres that jointly own the models, Secrecy and intellectual property block collaboration, Data silos.
Shares ClinicalTrials.gov, Secrecy and intellectual property block collaboration, Data silos.
Shares An antitrust safe harbour for cross-company combination trials and data pooling, Secrecy and intellectual property block collaboration.
Shares A shared library of pooled control arms to shrink and speed future trials, Secrecy and intellectual property block collaboration.
Shares A public registry of stalled academic assets and shelved company compounds, Secrecy and intellectual property block collaboration.
Shares An antitrust safe harbour for cross-company combination trials and data pooling, Secrecy and intellectual property block collaboration.
Shares Secrecy and intellectual property block collaboration, Data silos.
Shares ClinicalTrials.gov, Secrecy and intellectual property block collaboration, Data silos.